SEC filings
Zimmer Biomet (ZBH)
Recent filings Zimmer Biomet made with the SEC, newest first. Most have a short AI-generated summary, and every one links to the original.
CIK 0001136869All filings on SEC.gov
10-QQuarterly report
Quarterly report
Zimmer Biomet reported net sales of $2.06 billion for the quarter ended September 30, 2026, up 3.1% from a year earlier, and $6.33 billion for the nine months, up 5.7%. Knee sales fell 3.1% in the quarter amid a U.S. …
8-KCurrent report
Results of Operations and Financial Condition
Zimmer Biomet reported third-quarter 2026 net sales of $2.063 billion, up 3.1% on a reported basis and 3.7% in constant currency, with diluted earnings per share of $1.00 (down 13.8%) and adjusted diluted EPS of $1.90. …
8-KCurrent report
Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers; Regulation FD Disclosure
Zimmer Biomet said Kevin Thornal, Group President, Global Businesses and the Americas, will depart on September 30, 2026, and announced promotions effective October 1 of Gary Campbell to President, Americas, Brian Hatcher to President…
8-KCurrent report
Other Events
Zimmer Biomet filed a Form 8-K recasting portions of its 2025 annual report to reflect a change in operating segment composition, under which results of its Foot and Ankle business in EMEA and Asia Pacific and certain product category…
10-QQuarterly report
Quarterly report
Zimmer Biomet reported second-quarter 2026 net sales of $2.18 billion, up 4.8% from a year earlier, with U.S. sales up 5.6% to $1.24 billion and international sales up 3.7% to $937 million. …
8-KCurrent report
Results of Operations and Financial Condition
Zimmer Biomet reported second-quarter 2026 net sales of $2.177 billion, up 4.8% year over year, with diluted earnings per share of $1.03 and adjusted diluted earnings per share of $2.07, and raised its full-year 2026 revenue and adjusted…
Readster writes AI-generated summaries of public filings for research purposes only. Summaries can be incomplete or wrong — check the original filing on SEC.gov before relying on it. Nothing here is investment, legal or medical advice.
Follow Zimmer Biomet in Readster
Add Zimmer Biomet to your watchlist and its SEC filings reach your brief alongside the news about it, every line cited to its source. Readster also follows topics, people, newsletters and podcasts.
No credit card. When the trial ends, you move to Readster Free unless you subscribe.